Ally Olotu

3.9k total citations
45 papers, 1.5k citations indexed

About

Ally Olotu is a scholar working on Public Health, Environmental and Occupational Health, Virology and Immunology. According to data from OpenAlex, Ally Olotu has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Public Health, Environmental and Occupational Health, 8 papers in Virology and 8 papers in Immunology. Recurrent topics in Ally Olotu's work include Malaria Research and Control (32 papers), Mosquito-borne diseases and control (24 papers) and HIV Research and Treatment (8 papers). Ally Olotu is often cited by papers focused on Malaria Research and Control (32 papers), Mosquito-borne diseases and control (24 papers) and HIV Research and Treatment (8 papers). Ally Olotu collaborates with scholars based in Kenya, United Kingdom and Tanzania. Ally Olotu's co-authors include Philip Bejon, Kevin Marsh, Juliana Wambua, Greg Fegan, George Nyangweso, Marc Lievens, Amanda Leach, Patricia Njuguna, David C. Kaslow and Edna Ogada and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Ally Olotu

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ally Olotu Kenya 19 1.1k 386 298 184 170 45 1.5k
Tom Doherty United Kingdom 18 1.1k 1.0× 316 0.8× 315 1.1× 246 1.3× 251 1.5× 31 1.6k
Amagana Dolo Mali 26 1.3k 1.1× 504 1.3× 257 0.9× 120 0.7× 309 1.8× 67 1.8k
Alfred Amambua‐Ngwa Gambia 24 1.5k 1.3× 379 1.0× 345 1.2× 150 0.8× 307 1.8× 105 1.8k
Juliana Wambua Kenya 16 802 0.7× 211 0.5× 166 0.6× 135 0.7× 134 0.8× 23 1.0k
Dhanpat Kumar Kochar India 17 1.6k 1.4× 270 0.7× 230 0.8× 177 1.0× 433 2.5× 44 1.8k
Jon Eric Tongren United States 19 1.5k 1.3× 777 2.0× 212 0.7× 206 1.1× 338 2.0× 28 2.0k
Inoni Betuela Papua New Guinea 20 1.6k 1.4× 361 0.9× 254 0.9× 95 0.5× 432 2.5× 39 1.8k
Matthew B. B. McCall Netherlands 21 1.3k 1.2× 870 2.3× 337 1.1× 241 1.3× 377 2.2× 56 2.0k
Kirsten E. Lyke United States 26 1.6k 1.5× 827 2.1× 333 1.1× 331 1.8× 427 2.5× 61 2.5k
Safiatou Doumbo Mali 21 1.9k 1.7× 637 1.7× 269 0.9× 292 1.6× 401 2.4× 41 2.4k

Countries citing papers authored by Ally Olotu

Since Specialization
Citations

This map shows the geographic impact of Ally Olotu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ally Olotu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ally Olotu more than expected).

Fields of papers citing papers by Ally Olotu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ally Olotu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ally Olotu. The network helps show where Ally Olotu may publish in the future.

Co-authorship network of co-authors of Ally Olotu

This figure shows the co-authorship network connecting the top 25 collaborators of Ally Olotu. A scholar is included among the top collaborators of Ally Olotu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ally Olotu. Ally Olotu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bellamy, Duncan, Rodney Ogwang, Domtila Kimani, et al.. (2025). Vaccine-induced responses to R21/Matrix-M – an analysis of samples from a phase 1b age de-escalation, dose-escalation trial. Frontiers in Immunology. 16. 1620366–1620366.
5.
Miura, Kazutoyo, Ababacar Diouf, Michael P. Fay, et al.. (2023). Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies. Malaria Journal. 22(1). 159–159. 8 indexed citations
6.
Finda, Marceline F., et al.. (2022). Barriers and drivers of voluntary blood donation in northern and Western Tanzania. 5. 6–6. 2 indexed citations
7.
Sabot, Oliver, Alejandro Llanos‐Cuentas, Ally Olotu, et al.. (2021). COVID-19 Therapeutics for Low- and Middle-Income Countries: A Review of Candidate Agents with Potential for Near-Term Use and Impact. American Journal of Tropical Medicine and Hygiene. 105(3). 584–595. 9 indexed citations
9.
Gitaka, Jesse, Caroline Ogwang, Moses M. Ngari, et al.. (2017). Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study. PLoS ONE. 12(5). e0177382–e0177382. 8 indexed citations
10.
Rono, Josea, Anna Färnert, Linda Murungi, et al.. (2015). Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity. BMC Medicine. 13(1). 114–114. 18 indexed citations
11.
White, Michael, Philip Bejon, Ally Olotu, et al.. (2014). A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine. BMC Medicine. 12(1). 117–117. 2 indexed citations
12.
Warimwe, George M., Helen A. Fletcher, Ally Olotu, et al.. (2013). Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data. BMC Medicine. 11(1). 184–184. 31 indexed citations
13.
Kamuya, Dorcas, Patricia Njuguna, Ally Olotu, et al.. (2013). Feedback of Research Findings for Vaccine Trials: Experiences from Two Malaria Vaccine Trials Involving Healthy Children on the Kenyan Coast. Developing World Bioethics. 13(1). 48–56. 7 indexed citations
14.
Olotu, Ally, Greg Fegan, Juliana Wambua, et al.. (2013). Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure. New England Journal of Medicine. 368(12). 1111–1120. 173 indexed citations
15.
White, Michael, Philip Bejon, Ally Olotu, et al.. (2013). The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection. PLoS ONE. 8(4). e61395–e61395. 122 indexed citations
16.
Roetynck, Sophie, Ally Olotu, Kevin Marsh, et al.. (2013). Phenotypic and Functional Profiling of CD4 T Cell Compartment in Distinct Populations of Healthy Adults with Different Antigenic Exposure. PLoS ONE. 8(1). e55195–e55195. 20 indexed citations
17.
18.
Bejon, Philip, Louise Turner, Thomas Lavstsen, et al.. (2011). Serological Evidence of Discrete Spatial Clusters of Plasmodium falciparum Parasites. PLoS ONE. 6(6). e21711–e21711. 29 indexed citations
19.
Bejon, Philip, Thomas N. Williams, Anne Liljander, et al.. (2010). Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya. PLoS Medicine. 7(7). e1000304–e1000304. 183 indexed citations
20.
Olotu, Ally, Moses Ndiritu, Shebe Mohammed, et al.. (2008). Characteristics and outcome of cardiopulmonary resuscitation in hospitalised African children. Resuscitation. 80(1). 69–72. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026